HHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harte Hanks Inc (HHS) is not a good buy for a beginner investor with a long-term strategy at this time. The company is facing significant financial challenges, including declining revenue, net income, and EPS. Technical indicators suggest a bearish trend, and there are no clear positive catalysts or strong trading signals to justify an immediate investment.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 35.705, showing no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 2.668 and resistance at 2.748.
NULL identified. The company is focusing on cost control and business optimization, but these are long-term strategies with no immediate impact.
Revenue declined by 15.4% YoY in Q4 2025 due to weak market demand and increased competition. Net income and EPS dropped significantly (-190.47% and -190.91% YoY, respectively). Gross margin also declined by 9.82% YoY.
In Q4 2025, Harte Hanks reported a revenue decline to $39.86 million (-15.43% YoY), a net income drop to $2.2 million (-190.47% YoY), and an EPS decline to $0.30 (-190.91% YoY). Gross margin decreased to 14.6% (-9.82% YoY).
No analyst rating or price target changes available. Wall Street sentiment is neutral, with no strong opinions on the stock.
